참고문헌
- Andl CD (2010). The Misregulation of Cell Adhesion Components during Tumorigenesis: Overview and Commentary. J Oncol, 2010, 174715.
- Ba JL, Liu CG, Jin F (2014). Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis. Asian Pac J Cancer Prev, 15, 9233-9. https://doi.org/10.7314/APJCP.2014.15.21.9233
- Bailey ST, Miron PL, Choi YJ, et al (2014). NF-kappaB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth. Mol Cancer Res, 12, 408-20. https://doi.org/10.1158/1541-7786.MCR-13-0206-T
- Brady SW, Zhang J, Seok D, et al (2014). Enhanced PI3K p110alpha signaling confers acquired lapatinib resistance that can be effectively reversed by a p110alpha-selective PI3K inhibitor. Mol Cancer Ther, 13, 60-70.
- Chang WT, Cheng HL, Hsieh BS, et al (2014). Progesterone increases apoptosis and inversely decreases autophagy in human hepatoma HA22T/VGH cells treated with epirubicin. Scientific World J, 2014, 567148.
- Chen HY, Chen XY (2013). Tetrandrine reversed the resistance of tamoxifen in human breast cancer MCF-7/TAM cells: an experimental research. Zhongguo Zhong Xi Yi Jie He Za Zhi, 33, 488-91.
- Cufi S, Vazquez-Martin A, Oliveras-Ferraros C, et al (2013). The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer. Sci Rep, 3, 2469.
- De Luca A, D'Alessio A, Gallo M, et al (2014). Src and CXCR4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib. Cell Cycle, 13, 148-56. https://doi.org/10.4161/cc.26899
- Eke I, Cordes N (2014). Focal adhesion signaling and therapy resistance in cancer. Semin Cancer Biol.
- Eljack ND, Ma HY, Drucker J, et al (2014). Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin. Metallomics, 6, 2126-33. https://doi.org/10.1039/C4MT00238E
- Formisano L, Nappi L, Rosa R, et al (2014). Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. Breast Cancer Res, 16, 45.
- Froidevaux-Klipfel L, Poirier F, Boursier C, et al (2011). Modulation of septin and molecular motor recruitment in the microtubule environment of the Taxol-resistant human breast cancer cell line MDA-MB-231. Proteomics, 11, 3877-86. https://doi.org/10.1002/pmic.201000789
- Gao JL, Ji X, He TC, et al (2013). Tetrandrine suppresses cancer angiogenesis and metastasis in 4T1 tumor bearing mice. Evid Based Complement Alternat Med, 2013, 265061.
- Hardy KD, Wahlin MD, Papageorgiou I, et al (2014). Studies on the role of metabolic activation in tyrosine kinase inhibitor-dependent hepatotoxicity: induction of CYP3A4 enhances the cytotoxicity of lapatinib in HepaRG cells. Drug Metab Dispos, 42, 162-71.
- Howe EN, Cochrane DR, Cittelly DM, et al (2012). miR-200c targets a NF-kappaB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer. PLoS One, 7, 49987. https://doi.org/10.1371/journal.pone.0049987
- Huang YH, Zhang SH, Zhen RX, et al (2004). Asiaticoside inducing apoptosis of tumor cells and enhancing anti-tumor activity of vincristine. Ai Zheng, 23, 1599-604.
- Janji B, Vallar L, Al Tanoury Z, et al (2010). The actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner. J Cell Mol Med, 14, 1264-75. https://doi.org/10.1111/j.1582-4934.2009.00918.x
- Kacan T, Altun A, Altun GG, et al (2014). Investigation of antitumor effects of sorafenib and lapatinib alone and in combination on MCF-7 breast cancer cells. Asian Pac J Cancer Prev, 15, 3185-9. https://doi.org/10.7314/APJCP.2014.15.7.3185
- Kim HP, Han SW, Song SH, et al (2014). Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer. Oncogene, 33, 3334-41. https://doi.org/10.1038/onc.2013.285
- Kumar S, Park SH, Cieply B, et al (2011). A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Mol Cell Biol, 31, 4036-51. https://doi.org/10.1128/MCB.01342-10
- Lamb J, Crawford ED, Peck D, et al (2006). The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 313, 1929-35. https://doi.org/10.1126/science.1132939
- Li J, Cho YY, Langfald A, et al (2011). Lapatinib, a preventive/therapeutic agent against mammary cancer, suppresses RTK-mediated signaling through multiple signaling pathways. Cancer Prev Res (Phila), 4, 1190-7. https://doi.org/10.1158/1940-6207.CAPR-10-0330
- Li Z, Tian T, Hu X, et al (2013a). Six1 mediates resistance to paclitaxel in breast cancer cells. Biochem Biophys Res Commun, 441, 538-43. https://doi.org/10.1016/j.bbrc.2013.10.131
- Li Z, Tian T, Lv F, et al (2013b). Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression. PLoS One, 8, 59203. https://doi.org/10.1371/journal.pone.0059203
- Liu L, Greger J, Shi H, et al (2009). Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. Cancer Res, 69, 6871-8. https://doi.org/10.1158/0008-5472.CAN-08-4490
- Liu Y, Ge J, Li Q, et al (2013). Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK. Neoplasma, 60, 101-10.
- McDermott MS, Browne BC, Conlon NT, et al (2014). PP2A inhibition overcomes acquired resistance to HER2 targeted therapy. Mol Cancer, 13, 157. https://doi.org/10.1186/1476-4598-13-157
- Mithraprabhu S, Khong T, Spencer A (2014). Overcoming inherent resistance to histone deacetylase inhibitors in multiple myeloma cells by targeting pathways integral to the actin cytoskeleton. Cell Death Dis, 5, 1134. https://doi.org/10.1038/cddis.2014.98
- Ramsay EE, Dilda PJ (2014). Glutathione S-conjugates as prodrugs to target drug-resistant tumors. Front Pharmacol, 5, 181.
- SA VONS-H, Schmeel LC, Schmeel FC, et al (2014). Targeting the Wnt/beta-catenin pathway in renal cell carcinoma. Anticancer Res, 34, 4101-8.
- Schroeder RL, Stevens CL, Sridhar J (2014). Small molecule tyrosine kinase inhibitors of ErbB2/HER2/Neu in the treatment of aggressive breast cancer. Molecules, 19, 15196-212. https://doi.org/10.3390/molecules190915196
- Tang L, Wang Y, Strom A, et al (2013). Lapatinib induces p27 (Kip1)-dependent G (1) arrest through both transcriptional and post-translational mechanisms. Cell Cycle, 12, 2665-74. https://doi.org/10.4161/cc.25728
- Truman JP, Garcia-Barros M, Obeid LM, et al (2014). Evolving concepts in cancer therapy through targeting sphingolipid metabolism. Biochim Biophys Acta, 1841, 1174-88. https://doi.org/10.1016/j.bbalip.2013.12.013
- Ueki N, Lee S, Sampson NS, et al (2013). Selective cancer targeting with prodrugs activated by histone deacetylases and a tumour-associated protease. Nat Commun, 4, 2735.
- Wang P, Yuan HH, Zhang X, et al (2014). Novel lycorine derivatives as anticancer agents: synthesis and in vitro biological evaluation. Molecules, 19, 2469-80. https://doi.org/10.3390/molecules19022469
- Wang Q, Quan H, Zhao J, et al (2013). RON confers lapatinib resistance in HER2-positive breast cancer cells. Cancer Lett, 340, 43-50. https://doi.org/10.1016/j.canlet.2013.06.022
- Wilson AJ, Liu AY, Roland J, et al (2013). TR3 modulates platinum resistance in ovarian cancer. Cancer Res, 73, 4758-69. https://doi.org/10.1158/0008-5472.CAN-12-4560
- Xu CY, Jiang ZN, Zhou Y, et al (2013). Estrogen receptor alpha roles in breast cancer chemoresistance. Asian Pac J Cancer Prev, 14, 4049-52. https://doi.org/10.7314/APJCP.2013.14.7.4049
- Zhang Z, Wang J, Ji D, et al (2014). Functional genetic approach identifies MET, HER3, IGF1R, INSR pathways as determinants of lapatinib unresponsiveness in HER2-positive gastric cancer. Clin Cancer Res, 20, 4559-73. https://doi.org/10.1158/1078-0432.CCR-13-3396
- Zhao Q, Wu CZ, Lee JK, et al (2014). Anticancer effects of the Hsp90 inhibitor 17-demethoxy-reblastatin in human breast cancer MDA-MB-231 cells. J Microbiol Biotechnol, 24, 914-20.
- Zhou H, Shen T, Shang C, et al (2014). Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway. Oncotarget, 5, 10140-50. https://doi.org/10.18632/oncotarget.2471
피인용 문헌
- Identification of Biomarkers for Breast Cancer Using Databases vol.21, pp.4, 2016, https://doi.org/10.15430/JCP.2016.21.4.235